IMPROVE-IT: A Final Closure to Carcinogenicity of Ezetimibe? JACC. CardioOncology Lewis, E. F., Rhee, J. W. 2020; 2 (3): 397-399

View details for DOI 10.1016/j.jaccao.2020.08.003

View details for PubMedID 34396247

View details for PubMedCentralID PMC8352260